Masimo Corporation (MASI)
Net profit margin
Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
---|---|---|---|---|---|---|
Net income | US$ in thousands | 81,500 | 143,500 | 229,639 | 240,302 | 196,216 |
Revenue | US$ in thousands | 2,053,900 | 2,073,900 | 1,239,150 | 1,143,740 | 937,837 |
Net profit margin | 3.97% | 6.92% | 18.53% | 21.01% | 20.92% |
December 31, 2023 calculation
Net profit margin = Net income ÷ Revenue
= $81,500K ÷ $2,053,900K
= 3.97%
The net profit margin of Masimo Corporation has exhibited a downward trend over the past five years. In 2023, the net profit margin decreased to 3.97% from 6.92% in 2022, marking a significant decline. This decrease indicates that the company's profitability relative to its revenue has weakened. The net profit margin was highest in 2020 at 21.01% and has shown a consistent decline since then. It is important for Masimo Corporation to closely monitor and address the factors contributing to this declining trend in order to sustain or improve its profitability levels in the future.
Peer comparison
Dec 31, 2023
Company name
Symbol
Net profit margin
Masimo Corporation
MASI
3.97%
BioLife Solutions Inc
BLFS
-46.57%
CONMED Corporation
CNMD
5.18%
LivaNova PLC
LIVN
1.60%
Medtronic PLC
MDT
11.15%